Grossesse sous efavirenz (Sustiva®) : à  propos de 12 cas de patientes positives pour le VIH

In the English literature published, although the prevalence of abnormalities in human is low (1,7%) during pregnancy, due to the potent teratogenicity, efavirenz is contraindicated in the first trimester and should be used with caution in women of childbearing potential.